References
- Julian D. Translation of clinical trials into clinical practice. J Intern Med. 2004;255:309–316.
- Zarin D, Tse T. Moving towards transparency of clinical trials. Science. 2008;319:1340–1342.
- Getz K, Hallinan Z, Simmons D, et al. Meeting the obligation to communicate clinical trial results to study volunteer. Expert Rev Clin Pharmacol. 2012;5(2):149–156.
- Shalowitz D, Miller F. Communicating the results of clinical research to participants: attitudes, practices and future directions. PLoS Med. 2008;5(5):714–720.
- America’s health literacy: why we need accessible health information. Report from the Department of Health and Human Services; [cited 2019 Jan 7]. Available from: https://health.gov/communication/literacy/issuebrief/
- Health literacy. Report from the World Health Organization; [cited 2019 Jan 7]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0008/190655/e96854.pdf
- Law M, Kawasumi Y, Morgan S. Despite law far fewer than one in eight completed studies of drugs and biologics are reported on ClinicalTrials.gov. Health Affairs. 2011;30:2338–2345.
- Anderson M, Chiswell K, Peterson E, et al. Compliance with results reporting at ClincialTrials.gov. N Eng J Med. 2015;372(11):1031–1039.
- Goldacre B, DeVito N, Heneghan C, et al. Compliance with requirement to report results on the EU clinical trials register: cohort study and web resource. BMJ Open. 2018;362:k3218.
- Powell-Smith A, Goldacre B. The trials tracker: automated ongoing monitoring of failure to share clinical trial results by all major companies and research institutions. F1000Res. 2016;5(2629):1–11.
- Forster D, McNair L, Picard B. Returning study results to research participants: best practices for preparation and institutional review board oversight. White paper from WCG; [cited 2019 Jan 4]. Available from: http://www.appliedclinicaltrialsonline.com/returning-study-results-research-participants-best-practices-preparation-and-institutional-review-bo?dlCookieTest=1
- DiMasi J, Grabowski H, Hansen R. Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ. 2016;47:20–33.
- Stergiopoulos S, Getz K, Blazynski C. Evaluating the completeness of ClinciaTrials.gov. TIRS. Published online May 2018.
- Kuhn B. Few studies reporting results at US government clinical trial sites. JAMA. 2012;307(7):651–652.
- Long C, Stewart M, McElfish P. Health research participants are not receiving research results: a collaborative approach is needed. BMC. 2017;18:449.
- Hallinan Z, Getz K. Advancing the research enterprise: establishing a new standard practice for disseminating clinical trial results to study volunteers. Clin Res. 2014;28:24–29.
- Stergiopoulos S, Michaels D, Kunz B, et al. Measuring the impact of patient engagement and patient centricity in clinical research and development. TIRS. Published online Jan 2019.
- Levitan B, Getz K, Eisenstein E, et al. Assessing the financial value of patient engagement. TIRS. 2017;52(2):220–229.
- Anderson A, Borfitz B, Getz K. Global attitudes about clinical research and patient experiences with clinical trials. JAMA Network Open. 2018;1(6):e182969.
- Fortunato A, Grainger D, Abou-El-Enein M. Enhancing patient-level clinical data access to promote evidence-based practice and incentive therapeutic innovation. Adv Drug Deliv Rev. 2018;136–137:97–104.